Clinical Audit on the Managment in Assiut University Children Hospital
Overview
clinical audit on the Managment of rheumatic fever in assiut university children hospital.
Full Title of Study: “Clinical Audit on the Managment of Rheumatic Fever in Assiut University Children Hospital”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: March 24, 2020
Detailed Description
Acute rheumatic fever,an auto immune response to Group A streptococcus infection of the upper respiratory tract,may result in carditis.when the inflammation leads to permenant damage of the valves the individual has rheumatic heart disease. Recurrences of rheumatic fever are likely in the absence of preventive measures and may cause further cardiac valve and muscle damage,leading to heart failure,stroke and premature death.bacterial endocarditis is also a complication.
Interventions
- Diagnostic Test: C reactive protein, anti streptolysin o antibody test ,erythrocyte sedimentation rate
- Throat culture to detect the causative organism
Clinical Trial Outcome Measures
Primary Measures
- laboratory investigations (ASOt , ESR . CRP)
- Time Frame: One year from October 2017 to september 2018
- laboratory investigations that measure the inflammation process will be used and the target that the ASOt not increase 1/400
Secondary Measures
- clinical measures
- Time Frame: One year from October 2017 to september 2018
- improvement of arthritis if found
Participating in This Clinical Trial
Inclusion Criteria
- patients with confirmed diagnosis of rheumatic fever based on laboratory investigations. Exclusion Criteria:
- No
Gender Eligibility: All
Minimum Age: 5 Years
Maximum Age: 15 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Assiut University
- Provider of Information About this Clinical Study
- Principal Investigator: Patricia reda hanna, Resident doctor – Assiut University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.